NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myelomonocytic leukaemia

Download NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myelomonocytic leukaemia publication

Reference:

Miller Whitney, Holden J, George E, Stein K. NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myelomonocytic leukaemia. The Lancet Oncology 2011;12(4): 326-327.